Roche Genentech:Our Approach
Our Approach
About Us
https://www.gene.com
Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical ...
Genentech
https://www.gene.com
Breakthrough science. One moment, one day, one person at a time.
Genentech R&D (gRED)
https://www.roche.com
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life- ...
Our Pipeline
https://www.gene.com
Oncology; Immunology; Neuroscience; Metabolism; Infectious Disease; Ophthalmology; Other; Managed by Roche. Phase I Phase II Phase III. Molecule. Phase.
Visit us
https://www.gene.com
Following our March 2009 merger with Roche, Genentech's South San Francisco campus became the headquarters for Roche pharmaceutical operations in the United ...
基因泰克
https://zh.wikipedia.org
基因泰克公司(英語:Genentech Inc.),全名基因工程科技公司(英語:Genetic ... 羅氏藥廠於2009年3月26日以大約468億美元完成了基因泰克的收購,並完全擁有此公司。
羅氏集團
https://www.roche.com.tw
羅氏是全球最大的生物科技公司,擁有在癌症、免疫、感染性疾病、眼科及中樞神經系統等領域的獨特藥品。羅氏也在體外診斷、癌症組織診斷居於世界領導地位,並在糖尿病管理 ...